Josh Makower retweeted
To celebrate Tom Krummel's retirement from Stanford, we gathered for an evening of #storytelling. Tom is continuing as a senior advisor for Biodesign and board chair @FogartyInnov so we're not sure this counts as retirement but we miss you already TK! #healthtech #innovation
Josh Makower retweeted
Don't miss part 2! @FogartyInnov CEO Andrew Cleeland interviews @joshatnea, an engineer, physician, serial medtech entrepreneur, venture capitalist, musician, artist, wine connoisseur, and the new director of Stanford Biodesign. #medtechtrailblazers youtube.com/watch?v=TRdAGxk-…
Josh Makower retweeted
“One of the greatest thrills in life is to do something that's never been done before. It’s about breaking new ground and improving outcomes for patients.” Watch the 1st #MedTechTrailblazers episode with
@joshatnea, incoming director of @SUBiodesign: youtube.com/watch?v=Gklz59UJ…
Josh Makower retweeted
CONGRATULATIONS and welcome back @joshatnea! We're excited to welcome you as the new director of Stanford Biodesign starting August 1. More details in a news story coming tomorrow, stay tuned! @exploramed @JoshAtCoravin #healthtech #innovation #training
Josh Makower retweeted
“Hearing that Josh was interested in the director position was like finding out Steph Curry is eligible to play on your college basketball team. We're delighted to welcome him back to Stanford Biodesign.” @PaulYockMD @joshatnea @exploramed @JoshAtCoravin med.stanford.edu/news/all-ne…
Josh Makower retweeted
Happy to see @SUBiodesign well-represented in this discussion about the the future of #innovation in #healthtech moderated by fellowship co-founder @exploramed and alumni fellow @KateRosenbluth. #mentorship teapawt.org/IngensityIP/status/100…
Josh Makower retweeted
.@ExploraMed president Eb Bright: we need strong #patents to turn ideas into products. Yet, because of bad changes to the #patent system, we've seen very little early stage investment going to the small inventors with big ideas. #PatentsMatter
Josh Makower retweeted
#Healthtech #innovation training: clues that you've uncovered an important problem in healthcare: patient morbidity, poor outcomes, high costs, the comment, "If only I had a way to..." Biodesign Executive Education 2018 #medtech
Josh Makower retweeted
Congratulations @AntonCliff #moximed team • @nea @joshatnea @exploramed teapawt.org/joshatcoravin/status/8… – at Stanford, CA
Moximed: First Patient Treated in US Study of Atlas® System for Unicompartmental Knee ... - goo.gl/alerts/1nxwJ #GoogleAlerts
Josh Makower retweeted
Willow wearable breast pump allows moms to not have to choose between work and breastfeeding @willowpump @exploramed engt.co/2j7Amrb
Josh Makower retweeted
Smart breast pump lets moms multitask - CNNMoney cnnmon.ie/2iSoE4e @nea @CNN @willowpump @exploramed – at Paradise, NV
Josh Makower retweeted
Smart breast pump lets moms multitask - CNNMoney cnnmon.ie/2iSoE4e @nea @CNN @willowpump @exploramed
Josh Makower retweeted
Willow wearable breast pump • a transformational product for new moms and babies @CNET @willowpump @nea @exploramed cnet.com/products/willow-wea… – at Paradise, NV
Josh Makower retweeted
Willow wearable breast pump • a transformational product for new moms and babies @CNET @willowpump @nea @exploramed cnet.com/products/willow-wea…
Josh Makower retweeted
Dr. Dyche completed the first 6 UroLift cases in Iowa. Patients were treated in the office setting and very happy!
Josh Makower retweeted
Watch @wizofneworleans's discussion on UroLift vs. TURP: New gold standard for BPH? #Urology ow.ly/MboD301Ukck
Josh Makower retweeted
NeoTract Announces UroLift System Now Available to Millions More Americans dlvr.it/Ll8MVz
Josh Makower retweeted
Special thanks to Professor McNicholas @RoySocMed for his generous invitation to speak today @NEAVC @NeoTractInc – at Paddington, London
